scorecardresearchMetropolis Healthcare Share Price Live NSE, BSE, Today - Metropolis Healthcare Stock Price
Mintgenie
Asian Paints3,235.15-5.30 (-0.16%)
Axis Bank926.006.50 (0.71%)
Bajaj Finance7,023.00-17.80 (-0.25%)
Bajaj Finserve1,456.556.15 (0.42%)
Bharti Airtel836.208.15 (0.98%)
HCL Technologies1,136.90-4.30 (-0.38%)
HDFC Bank1,606.152.05 (0.13%)
Hindustan Unilever2,716.3518.60 (0.69%)
Housing Development Finance Corporation2,641.35-4.45 (-0.17%)
ICICI Bank937.051.00 (0.11%)
ITC443.203.40 (0.77%)
Indusind Bank1,288.10-3.15 (-0.24%)
Infosys1,298.65-20.80 (-1.58%)
Kotak Mahindra Bank1,939.7511.25 (0.58%)
Larsen & Toubro2,235.2526.20 (1.19%)
Mahindra & Mahindra1,341.4022.55 (1.71%)
Maruti Suzuki India9,488.80161.00 (1.73%)
NTPC174.20-0.10 (-0.06%)
Nestle India22,020.00161.10 (0.74%)
Power Grid Corporation Of India234.601.70 (0.73%)
Reliance Industries2,454.95-7.10 (-0.29%)
State Bank Of India587.204.60 (0.79%)
Sun Pharmaceutical Industries999.3511.85 (1.20%)
Tata Consultancy Services3,308.00-15.30 (-0.46%)
Tata Motors535.750.50 (0.09%)
Tata Steel108.002.05 (1.93%)
Tech Mahindra1,122.301.35 (0.12%)
Titan Company2,859.6032.90 (1.16%)
Ultratech Cement7,849.406.70 (0.09%)
Wipro404.80-2.45 (-0.60%)

Metropolis Healthcare

BSE: 542650 | NSE: METROPOLIS | ISIN: INE112L01020 | SECTOR: Healthcare Facilities

₹1,310.90 4.25 (0.33%)

02 Jun 2023, 09:59 (IST)

  • Open

    1,303.05

  • High

    1,315.00

  • Low

    1,298.15

  • Prev Close

    1,306.65

  • P/E

    -

  • Median P/E

    -

  • P/B

    -

  • Median P/B

    -

  • Market Cap

    67.13B

  • Volume

    2.53K

  • Vol. (20 day Avg.)

    0

  • PEG

    -

  • Div.Yield

    -

  • Bid

    1,311.95

  • Ask

    -
View all metrics

Promoter Pledge Holding - 0.59%

Promoter NameNo of SharesPercentage
Metz Advisory LLP3,00,0000.58%

Company Description

  • Healthcare Facilities

  • BSE

    542650

  • NSE

    METROPOLIS

  • ISIN

    INE112L01020

Metropolis Healthcare Limited is an India-based diagnostics company that operates through the pathology services segment. The Company offers a range of clinical laboratory tests and profiles, which are used for prediction, early detection, diagnostic screening, confirmation and monitoring of the disease. The Company also offers analytical and support services to clinical research organizations for their clinical research projects. Its services include pathology testing services, corporate wellness, lab in hospitals and clinical research services. The Company offers a range of tests and profiles that include advanced tests in diagnosis of cancer, neurological disorders, infectious diseases, and an array of genetic abnormalities. It owns a chain of diagnostic centers across India, South Asia, Africa and the Middle East. The Company has spread its footprint across 20 Indian states and over 210 cities.

Company Officers

  • Sushil Shah

    Executive Chairman of the Board

  • Nilesh Shah

    Group President, Chief - Science & Innovation

  • Rakesh Agarwal

    Chief Financial Officer

  • Kannan Alangadan

    Chief Operating Officer - Operations, Healthtech Business and Services

  • Ishita Medhekar

    Chief Human Resource Officer

  • Kirti Chadha

    Chief Scientific Officer

  • Ameera Shah

    Managing Director, Executive Director

  • Sriram Iyer

    Chief Revenue Officer

  • Simmi Bisht

    Head - Legal and Secretarial, Company Secretary